The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027. Novo Nordisk's blockbuster diabetes drug ...

The executive order was the largest action to date by the second Trump administration on prescription drug costs but experts ...

In 2023, Medicare selected 10 drugs for its first round of price negotiations. Agreements were reached with drug manufacturers to establish new, reduced prices for all 10 drugs. These prices ...

Such a change has the potential to increase costs for the government, because it would most likely delay the existing timetable for some drugs to become eligible for Medicare price cuts.

Likewise, the order calls to match the Medicare payment for certain prescription drugs to the price that hospitals ... on the pharmaceutical sector were headed down the pipeline.

Currently, small molecule drugs become eligible for negotiated price cuts after they have been on ... The order also seeks to align Medicare reimbursement rates for specific drugs with the prices ...

Kennedy Jr. to provide the President with guidance on reform to the Medicare Drug Price Negotiation ... US states to import drugs from Canada. Despite sweeping staff cuts seen in recent weeks ...